Method to inject and extract fluid at a treatment site to remove debris

Information

  • Patent Grant
  • 6800075
  • Patent Number
    6,800,075
  • Date Filed
    Friday, August 30, 2002
    22 years ago
  • Date Issued
    Tuesday, October 5, 2004
    19 years ago
Abstract
A method and device for injecting and extracting fluid at a treatment site to remove debris from the site.
Description




FIELD OF THE INVENTION




The present invention relates to cardiology and more particularly to devices and methods for removing debris from vessels.











BRIEF DESCRIPTION OF THE DRAWINGS




Throughout the figures like reference numerals indicate equivalent structure wherein:





FIG. 1

is a schematic of the invention;





FIG. 2

is a schematic of the invention;





FIG. 3

is a schematic of the invention;





FIG. 4

is a schematic of the invention;





FIG. 5

is a schematic of the invention;





FIG. 6

is a schematic of the invention;





FIG. 7

is a schematic of the invention;





FIG. 8

is a schematic of the invention;





FIG. 9

is a schematic of the invention;





FIG. 10

is a schematic of the invention;





FIG. 11

is a schematic of the invention;





FIG. 12

is a schematic of the invention; and,





FIG. 13

is a schematic of the invention.











DETAILED DESCRIPTION





FIG. 8

shows the overall schematic of the treatment system. A guide sheath


10


with an optional occlusion balloon


12


is navigated to the treatment site


14


. A balloon catheter


16


with a distal fluid delivery port


18


or nozzle is passed trough the guide catheter


10


to the treatment site.




Fluid injected into the catheter


16


emerges from the catheter distal of the balloon


20


and induces a retrograde flow in the vessel


22


.




The injected fluid may be saline drugs or contrast agent or any biocompatible fluid. The source of fluid is selected from a conventional power injector


30


an irrigation bag suspended above the patient


32


, a conventional syringe or a Gemini syringe


34


.




The guide sheath is used to extract debris from the treatment site. The outflow passes trough a valve


40


, which is associated with a switch S


1


. Preferably the valve


40


is actuated by closing S


1


and/or the manual actuation of the valve sets the switch S


1


to logic


1


. The fluid drawn from the treatment site may be collected in a manual syringe


50


the low pressure side of Gemini


34


or a vacuum container


54


or a gravity fed collection bag


52


.




The balloon inflation port


60


is coupled to inflation syringe


62


and a deflation vacuum reservoir


64


through a switch valve S


2


. Inflation of the balloon proceeds normally but deflation is preferably performed in synchrony with the heart. The physician activates the physician switch PS when he wants to deflate the balloon


20


. Through logic, the valve S


2


is opened and the balloon quickly deflated at an appropriate point in the cardiac cycle.




The catheter is freely movable within the sheath


10


both before during and after the procedure. That is the nozzle


18


can be “on” while the catheter is moving relative to the sheath.





FIG. 1

shows a Gemini dual syringe


69


with an injection outlet


70


and an extraction or recovery inlet


72


. In this version of the device, it is attached to power injector


80


, which maybe turned on, by the switch S


3


. The plunger


74


sweeps out a volume and the displaced fluid is injected out of the port


70


. Recovered fluid from the sheath is collected at port


72


. In this fashion the volume injected and extracted are directly coupled.





FIG. 2

shows a manually operated Gemini dual syringe


73


with a hand plunger


75


. This version is useful for interventions where manual control of injection is desired.





FIG. 3

shows a “universal” Gemini dual syringe


77


where an additional injection ports


79


and power piston


81


drive a plunger


83


. The power inlet port


79


may couple to pump or power injector to control injection.




FIG.


4


and

FIG. 5

should be considered together as depicting a method of removing debris from a vessel. In

FIG. 4

, the balloon is inflated to treat the lesion


21


in vessel


22


. A fluid injection lumen


9


in the catheter terminates in a retrograde flow-inducing nozzle


18


. At the conclusion of the intervention, the balloon is quickly deflated while fluid is injected with nozzle


18


. The retrograde flow depicted by arrow


25


sweeps debris indicated by particle


27


into the open mouth of the guide catheter


10


. It is preferred to synchronize the balloon deflation with the fluid injection at a time when the flow in the guide catheter is at a maximum and coronary flow is at a minimum. This flow in the sheath


10


out the lumen


7


is propelled by either the low pressure side of a Gemini syringe


72


or a manual syringe or a vacuum container


54


or a gravity fed bag relying on aortic pressure to force flow in the sheath


10


lumen.




In the method of FIG.


4


and

FIG. 5

The occlusion of the vessel


22


with an occlusion balloon


12


is optional and used if the flow in the guide sheath lumen


7


is too low to collect all the injected fluid and debris.





FIG. 6

an

FIG. 7

show an alternate debris collection concept where fluid is injected through a guide wire lumen


90


without attempting to induce a retrograde flow. It should be appreciated that a dedicated fluid injection lumen may be used as an alternative. In

FIG. 6

an intervention takes place normally and in

FIG. 7

a large amount of fluid is injected into the vessel distal of the lesion to displace debris toward the open mouth of the guide sheath


10


. Particles such as


27


and particle


29


are forced into the guide sheath where they are evacuated. If the flow rate of the guide sheath exceeds the injected fluid flow rate then the debris will all be sucked out without the use of an optional occlusion balloon


12


.





FIG. 12

shows a QRS electrocardiograph tracing of the heart over a chart showing the time course of pressure in the aorta and flow in the coronary vessels. The optimal time to inject fluid into the coronary vessel may be when the flow in the vessels is very low


105


due to ventricular contraction. At the isovolumeic, time the aortic pressure is rising very fast


104


and this helps to promote vigorous flow in the guide sheath lumen


7


out of the body.





FIG. 11

shows a system to create the trigger time signal depicted as


107


in FIG.


12


. Conventional surface electrodes over the heart sense the cardiac depolarization and are amplified in a sense amplifier


109


this signal triggers a delay timer which may delay the activation of the remaining circuits for a few milliseconds. Depending on the overall architecture of the system any one of several approaches to controlling the system may be taken.




For example

FIG. 9

assumes that a catheter structure taught by

FIGS. 6 and 7

is set up with for example a conventional injector


30


coupled to the inlet


9


and a vacuum contain attached to the outlet port


40


. In this instance, the physician signals his desire to deflate the balloon by activating the physician switch P.S. This is ANDED with the next R0-wave signal processed to give the heart signal H.S. With the and condition satisfied the logic


110


drives the switches S! which opens the sheath lumen


7


to the collection vessel. Essentially simultaneously, the balloon


20


is deflated by valve S


2


. At essentially the same time, the injector


30


is turned on by switch S


3


. Under these conditions, the particles


27


are displaced toward the lumen


7


by the volume of injected fluid at


9


. Of course both anntegrade flow and retrograde flow occur with the simple fluid injection but the injected volume is set to exceed the ability of the vascular bed to accept the fluid forcing particulate retrograde into the waiting lumen


7


.




In

FIG. 10

a different architecture may be employed for example a manual syringe may be connected as a fluid source for injection


9


and a collection bag


52


. In this instance the physician signal to deflate is ANDED with the heart signal H.S. and the deflation switch S


2


quickly deflates the balloon


20


while the closure of S


4


allows fluid from the syringe to enter the vessel


22


through guidewire lumen in catheter


16


. The opening of valve


40


by the closure of switch S


1


allows the collected debris and blood and injectate to flow out of the system. Once these processes are started they may terminate within one heartbeat or they may continue over several beats. In general, the closure of the fluid injection process with precedes the closure of the sheath valve


40


.





FIG. 13

shows a simplified system for treating acute myocardial infarction. In these cases, the vessel is occluded by a plaque lesion, which is blocked by a clot. By pushing a catheter with a retrograde induction, nozzel


18


on it through the clot the clot is cleared and the clot debris may be collected by the sheath lumen. Again, the occlusion balloon


12


on the sheath


10


is optional. When used it is inflated just before the clot is crossed and is deflated as the nozzle


18


is retracted into the sheath


10


. Once again any fluid source and any collection vessel as depicted in

FIG. 8

may be used with this embodiment.




It must be recognized that various combinations of injectors and extractors as set forth in

FIG. 8

may be arranged to carry out the invention.



Claims
  • 1. A method of removing debris from a treatment site in a vessel comprising the steps of:occluding the vessel near a treatment site by inflating an occlusions balloon located on a delivery sheath of the type having an open lumen, said sheath located proximal of but near the therapy site; said vessel not being occluded distal of said therapy site by any medical device; inflating a therapy balloon located on a therapy catheter at the treatment site to provide a therapy, said therapy creating debris, said therapy catheter being capable of independent motion with respect to said delivery sheath; deflating said therapy balloon located on a therapy catheter at the treatment site, thereby releasing said debris; injecting fluid into the therapy site through at least one port in said therapy catheter at a location distal of the therapy site at a rate and quantity sufficient to displace the debris into said delivery sheath lumen.
CROSS REFERENCE

This application is a utility case based upon provisional applications U.S. 60/402680 filed Aug. 12, 2002 and U.S. 60/316122 filed Aug. 30, 2001 each is incorporated by reference herein in their entirety. The application is a CIP of U.S. Ser. No. 09/637,529 filed Aug. 11, 2000; U.S. Ser. No. 09/459,225 filed Dec. 10, 1999 now abandoned; U.S. Ser. No. 09/995,303 filed Nov. 27, 2001; U.S. Ser. No. 10/050,978 filed Jan. 18, 2002; U.S. Ser. No. 10/145,699 filed May 16, 2002. Each is incorporated by reference herein in their entirety.

US Referenced Citations (3)
Number Name Date Kind
5135482 Neracher Aug 1992 A
5250060 Carbo et al. Oct 1993 A
5462529 Simpson et al. Oct 1995 A
Provisional Applications (2)
Number Date Country
60/402680 Aug 2002 US
60/316122 Aug 2001 US
Continuation in Parts (5)
Number Date Country
Parent 10/145699 May 2002 US
Child 10/231507 US
Parent 10/050978 Jan 2002 US
Child 10/145699 US
Parent 09/995303 Nov 2001 US
Child 10/050978 US
Parent 09/637529 Aug 2000 US
Child 09/995303 US
Parent 09/459225 Dec 1999 US
Child 09/637529 US